Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study

BackgroundCardiovascular disease (CVD) remains a major contributor to the global disease burden. Previous studies have established a link between the atherogenic index of plasma (AIP) and CVD. However, it remains unclear whether cumulative AIP and AIP control influence the future incidence of CVD in...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Zhang, Yue Song, Yinfei Lu, Tao Liu, Ping Yin
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1517658/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542407413989376
author Yu Zhang
Yue Song
Yinfei Lu
Tao Liu
Ping Yin
author_facet Yu Zhang
Yue Song
Yinfei Lu
Tao Liu
Ping Yin
author_sort Yu Zhang
collection DOAJ
description BackgroundCardiovascular disease (CVD) remains a major contributor to the global disease burden. Previous studies have established a link between the atherogenic index of plasma (AIP) and CVD. However, it remains unclear whether cumulative AIP and AIP control influence the future incidence of CVD in individuals with Cardiovascular-Kidney-Metabolic (CKM) syndrome. This study aims to explore the association between cumulative AIP, AIP control levels, and the risk of CVD in individuals with CKM syndrome from stages 1 to 3.MethodsParticipants with CKM syndrome were drawn from the China Health and Retirement Longitudinal Study (CHARLS). Cumulative AIP was calculated using triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C), while AIP control levels were categorized into four groups via k-means clustering. CVD was defined by self-reported heart disease or stroke. Multivariable logistic regression and restricted cubic spline analysis were employed to examine the association between AIP and incident CVD in individuals with CKM syndrome.ResultsA total of 793 participants (18.84%) developed CVD. After adjusting for confounders, cumulative AIP were associated with the developing CVD (OR=1.139, 95% CI: 1.017-1.275, P=0.0245). Compared to group 1 (best AIP control), the OR (95% CI) for incident CVD were 1.278 (0.959-1.702) for group 2, 1.329 (1.076-1.641) for group 3, and 1.195 (0.974-1.465) for group 4. Restricted cubic spline regression indicated the relationship between cumulative AIP and CVD risk is linear (P for nonlinear = 0.3377).ConclusionsIn middle-aged and elderly individuals with CKM syndrome, higher cumulative AIP and poorer AIP control were associated with an elevated incidence of CVD. These findings suggest that enhanced assessment of the AIP index could inform targeted prevention strategies for CVD in the context of CKM syndrome.
format Article
id doaj-art-d62f48461b2f43d8a9aa92a902ab09eb
institution Kabale University
issn 1664-2392
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-d62f48461b2f43d8a9aa92a902ab09eb2025-02-04T05:28:10ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-02-011610.3389/fendo.2025.15176581517658Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal studyYu Zhang0Yue Song1Yinfei Lu2Tao Liu3Ping Yin4Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Cardiovascular Medicine, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Cardiovascular Medicine, Wuhan Red Cross Hospital, Wuhan, ChinaDepartment of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaBackgroundCardiovascular disease (CVD) remains a major contributor to the global disease burden. Previous studies have established a link between the atherogenic index of plasma (AIP) and CVD. However, it remains unclear whether cumulative AIP and AIP control influence the future incidence of CVD in individuals with Cardiovascular-Kidney-Metabolic (CKM) syndrome. This study aims to explore the association between cumulative AIP, AIP control levels, and the risk of CVD in individuals with CKM syndrome from stages 1 to 3.MethodsParticipants with CKM syndrome were drawn from the China Health and Retirement Longitudinal Study (CHARLS). Cumulative AIP was calculated using triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C), while AIP control levels were categorized into four groups via k-means clustering. CVD was defined by self-reported heart disease or stroke. Multivariable logistic regression and restricted cubic spline analysis were employed to examine the association between AIP and incident CVD in individuals with CKM syndrome.ResultsA total of 793 participants (18.84%) developed CVD. After adjusting for confounders, cumulative AIP were associated with the developing CVD (OR=1.139, 95% CI: 1.017-1.275, P=0.0245). Compared to group 1 (best AIP control), the OR (95% CI) for incident CVD were 1.278 (0.959-1.702) for group 2, 1.329 (1.076-1.641) for group 3, and 1.195 (0.974-1.465) for group 4. Restricted cubic spline regression indicated the relationship between cumulative AIP and CVD risk is linear (P for nonlinear = 0.3377).ConclusionsIn middle-aged and elderly individuals with CKM syndrome, higher cumulative AIP and poorer AIP control were associated with an elevated incidence of CVD. These findings suggest that enhanced assessment of the AIP index could inform targeted prevention strategies for CVD in the context of CKM syndrome.https://www.frontiersin.org/articles/10.3389/fendo.2025.1517658/fullCKM syndromeAIP indexCVDCHARLSthe elderly
spellingShingle Yu Zhang
Yue Song
Yinfei Lu
Tao Liu
Ping Yin
Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
Frontiers in Endocrinology
CKM syndrome
AIP index
CVD
CHARLS
the elderly
title Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
title_full Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
title_fullStr Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
title_full_unstemmed Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
title_short Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
title_sort atherogenic index of plasma and cardiovascular disease risk in cardiovascular kidney metabolic syndrome stage 1 to 3 a longitudinal study
topic CKM syndrome
AIP index
CVD
CHARLS
the elderly
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1517658/full
work_keys_str_mv AT yuzhang atherogenicindexofplasmaandcardiovasculardiseaseriskincardiovascularkidneymetabolicsyndromestage1to3alongitudinalstudy
AT yuesong atherogenicindexofplasmaandcardiovasculardiseaseriskincardiovascularkidneymetabolicsyndromestage1to3alongitudinalstudy
AT yinfeilu atherogenicindexofplasmaandcardiovasculardiseaseriskincardiovascularkidneymetabolicsyndromestage1to3alongitudinalstudy
AT taoliu atherogenicindexofplasmaandcardiovasculardiseaseriskincardiovascularkidneymetabolicsyndromestage1to3alongitudinalstudy
AT pingyin atherogenicindexofplasmaandcardiovasculardiseaseriskincardiovascularkidneymetabolicsyndromestage1to3alongitudinalstudy